This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
March 03, 2020
Targovax ASA: Invitation to presentation of Targovax’s fourth quarter 2019 results, Wednesday 11 March
March 02, 2020
Oncopeptides strengthens its organization by appointing Karolina Vilval as General Counsel
February 28, 2020
Year-end report 2019
February 27, 2020
Strongbridge Biopharma plc to Present at the Cowen and Company 40th Annual Healthcare Conference
February 27, 2020
Nordic Nanovector ASA – Results for the Fourth Quarter and Full Year 2019
February 26, 2020
Nordic Nanovector Appoints Dr Lars Nieba as interim Chief Executive Officer
February 25, 2020
Strongbridge Biopharma plc Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Corporate Update
February 21, 2020
Nordic Nanovector ASA: Invitation to Fourth Quarter and Full Year 2019 Results Presentation and Webcast
February 20, 2020
Interim Report Q4 2019
February 19, 2020
Strongbridge Biopharma plc to Host Fourth Quarter and Full-Year 2019 Financial Results Conference Call on February 25, 2020